DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ATU027
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ATU027
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PAPAIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PAPAIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A236A06Y32
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MLN-8054
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Neoplasms; Pancreatic Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
MLN-8054
×
Maximum Phase:
1
First Approval:
None
UNII:
BX854EHD63
Molecule Type:
Small molecule
Molecular Formula:
C25H15ClF2N4O2
Molecular Weight:
476.87
AlogP:
5.87
PSA:
87.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
F8Z9VSZ0K1
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
[18F]-FBA-A20FMDV2
1
Protein
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis
Unknown
[18F]-FBA-A20FMDV2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C100H167FN32O28
Molecular Weight:
2283.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SARS-COV
1
Unknown
Investigational
Unknown
Unknown
Coronavirus Infections; Severe Acute Respiratory Syndrome
Unknown
SARS-COV
×
Maximum Phase:
1
First Approval:
None
UNII:
R7D54R07N5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VACCINIA IMMUNE GLOBULIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
VACCINIA IMMUNE GLOBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7UB4J759TD
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RP-6530
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RP-6530
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ME-344
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Neoplasms
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ME-344
×
Maximum Phase:
1
First Approval:
None
UNII:
843G0TDV51
Molecule Type:
Small molecule
Molecular Formula:
C22H20O4
Molecular Weight:
348.4
AlogP:
4.42
PSA:
69.92
HBD:
3.0
HBA:
#RotB:
2.0
Source:
NUMIDARGISTAT
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Multiple Myeloma; Neoplasms
Unknown
NUMIDARGISTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
IFD73D535A
Molecule Type:
Small molecule
Molecular Formula:
C11H22BN3O5
Molecular Weight:
287.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARBON BLACK
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CARBON BLACK
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CESIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CESIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
1KSV9V4Y4I
Molecule Type:
Small molecule
Molecular Formula:
Cs
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LIFIRAFENIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
LIFIRAFENIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8762XZS5ZF
Molecule Type:
Small molecule
Molecular Formula:
C25H17F3N4O3
Molecular Weight:
478.43
AlogP:
5.3
PSA:
89.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GSI-136
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
GSI-136
×
Maximum Phase:
1
First Approval:
None
UNII:
51JV4753AD
Molecule Type:
Small molecule
Molecular Formula:
C11H18ClNO3S2
Molecular Weight:
311.86
AlogP:
2.48
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ELSULFAVIRINE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Virus Diseases
Unknown
ELSULFAVIRINE
×
Maximum Phase:
1
First Approval:
None
UNII:
ZC4CGO0RUG
Molecule Type:
Small molecule
Molecular Formula:
C24H17BrCl2FN3O5S
Molecular Weight:
629.29
AlogP:
5.96
PSA:
125.36
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TAPOTOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Multiple Myeloma
Unknown
TAPOTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
97W7N9T08G
Molecule Type:
Small molecule
Molecular Formula:
C33H41ClN2O5S
Molecular Weight:
613.22
AlogP:
5.9
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SU-9516
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cyclin-dependent kinase 2 inhibitor
SU-9516
×
Maximum Phase:
1
First Approval:
None
UNII:
FD2SWT2SDI
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O2
Molecular Weight:
241.25
AlogP:
1.91
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Hemangiosarcoma; Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Melanoma
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1Z5YC3ME5N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GET-73
1
Small molecule
Investigational
Unknown
Unknown
Alcoholism
Unknown
GET-73
×
Maximum Phase:
1
First Approval:
None
UNII:
U5CLZ223FH
Molecule Type:
Small molecule
Molecular Formula:
C13H16F3NO2
Molecular Weight:
275.27
AlogP:
2.75
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
JNJ-68284528
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-68284528
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FXR-450
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FXR-450
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05230907
1
Unknown
Investigational
Unknown
Unknown
Cerebral Hemorrhage
Unknown
PF-05230907
×
Maximum Phase:
1
First Approval:
None
UNII:
W1DT53SAN0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOBELINE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity
Unknown
LOBELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
D0P25S3P81
Molecule Type:
Small molecule
Molecular Formula:
C22H27NO2
Molecular Weight:
337.46
AlogP:
4.24
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AG-270
1
Unknown
Investigational
Unknown
Unknown
Lymphoma
Unknown
AG-270
×
Maximum Phase:
1
First Approval:
None
UNII:
E1P2TDU69L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DHES0815A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DHES0815A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMP-110
1
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
AMP-110
×
Maximum Phase:
1
First Approval:
None
UNII:
7J6GS9QIF0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DMUC-4064A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DMUC-4064A
×
Maximum Phase:
1
First Approval:
None
UNII:
D5STG0624V
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E-7820
1
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Colorectal Neoplasms; Neoplasms; Rectal Neoplasms
Unknown
E-7820
×
Maximum Phase:
1
First Approval:
None
UNII:
TVH5K7949N
Molecule Type:
Small molecule
Molecular Formula:
C17H12N4O2S
Molecular Weight:
336.38
AlogP:
3.02
PSA:
109.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
QT44II3WZP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
102
103
104
105
106
107
108
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA